In Other News

• COVID-19 Group Testing Method Delivers Results 13 Times Faster than Individual Testing of Each Sample

• Novel 15-Minute Microfluidic DLD Assay Could Assess Severity of Immune Response to COVID-19 Infection

• New Mass Spectrometry-Based Technique Enables Ultrafast Identification of COVID-19 Biomarkers

• Evidence of SARS-CoV-2 Infecting Mouth’s Cells Further Confirms Reliability of Saliva Testing for Diagnosing COVID-19

• AACC Issues Updated Recommendations on Uses and Limitations of COVID-19 Antibody Tests

• Rapid Antigen Tests Better at Correctly Identifying COVID-19 in People with Symptoms than in People Without Symptoms

• Beckman Coulter's SARS-CoV-2 IgG II Antibody Test Receives FDA Emergency Use Authorization

• First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay Receives FDA EUA

• Carolina Liquid Chemistries Offers FDA Emergency Use Authorized POC COVID-19/Flu A&B Combo Test

• Highly Accurate Prognostic Test Predicts Personalized Risk of Severe Illness Due to SARS-CoV-2 Virus

• Ortho's VITROS SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA EUA for New Performance, Sensitivity Data

• Thermo Fisher Collaborates with Artificial to Accelerate COVID-19 Diagnostics

• Eurofins Launches Upgraded RT-PCR Kit for Identification of Mutations Associated with SARS-CoV-2 Variants of Concern

• Low Cost Pinprick COVID-19 Test Detects SARS-CoV-2 Antibodies in Drop of Blood in Under an Hour

• New Ultra-Absorptive Nanofiber Swabs Could Improve COVID-19 Test Sensitivity

• Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants

• BioMérieux BIOFIRE Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Becomes First COVID-19 Diagnostic Test to Obtain De Novo FDA Authorization

• Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours

• Rapid Saliva-Based Test for COVID-19 Antibodies Could Scale Up Testing to Track Spread of SARS-CoV-2

• Roche Launches New SARS-CoV-2 Variant Test to Monitor Emerging Coronavirus Mutations

• Snibe Diagnostic SARS-CoV-2 Antigen Assay Secures CE Mark

• New Saliva-Based COVID-19 Test is Less Invasive, More Accessible and Delivers Accurate Results at Lower Cost

• Non-Invasive Skin Swab Samples Enough to Quickly Detect COVID-19, Finds New Study